K

Angelini Ventures logo

Angelini Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

7

Common Fundraising Type

Series A

Therini Bio logo
Therini Bio

Biotech • Immunotherapies

SV Health Investors logo
Sanofi Ventures logo
MRL Ventures Fund logo
Foundation for a Better World logo

Therini Bio, Inc. develops fibrin-targeting immunotherapies to treat neurodegenerative diseases such as Alzheimer's Disease and Diabetic Macular Edema.

Series A
$39M
05/15/2025
Article
Nuevocor logo
Nuevocor

Biotechnology • Cardiomyopathies

Kurma Partners logo
SEEDS Capital logo
Highlight Capital logo
EDBI logo

Nuevocor is a biotechnology company developing treatments for genetic cardiomyopathies using its proprietary mechanobiology platform.

Series B
$45M
05/06/2025
Article
Vantis logo
Vantis

Digital healthcare • Chronic disease management

Twip Impact Ventures logo
firstminute logo
b2venture logo
Bayern Kapital logo

Vantis is a digital care innovation company that enhances chronic disease management through data-driven healthcare solutions, telemedicine, and AI-powered processes.

Series A
$10.9M
03/12/2025
Article
Nobi logo
Nobi

AI-powered • Smart lights

Nexus NeuroTech Ventures logo
EQT Life Sciences logo
Angelini Ventures logo
15th Rock logo

Nobi develops AI-powered smart lights designed to detect falls and enhance elderly care.

Series B
$36.2M
01/28/2025
Article
Neumirna Therapeutics logo
Neumirna Therapeutics

RNA therapies • Antisense Oligonucleotide

Invivo Partners logo
Innovestor logo
Angelini Ventures logo

Neumirna Therapeutics is a biotech company developing RNA-based therapies, focusing on an Antisense Oligonucleotide treatment for drug-resistant epilepsy.

Series A
$20.7M
01/08/2025
Article
Aptadir Therapeutics logo
Aptadir Therapeutics

Biotech • Myelodysplastic Syndrome

CDP Venture Capital SGR logo
Evotec logo
Angelini Ventures logo

Aptadir Therapeutics is a biotech company developing RNA-based inhibitors to treat Myelodysplastic Syndrome (MDS).

Seed
$1.6M
09/24/2024
Article
Freya Biosciences logo
Freya Biosciences

Biotech • Women's Reproductive Health

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Series A
$38M
12/12/2023
Article